FDA product code KLJ: Nad Reduction (U.V.), Phosphohexose Isomerase

KLJ is the FDA product code for nad reduction (u.v.), phosphohexose isomerase. It is a Class I device, regulated under 21 CFR 862.1570 and reviewed by the Clinical Chemistry panel. FDA has cleared 1 510(k) submission under KLJ. The average 510(k) review took 81 days (median 81).

Classification

FieldValue
Device nameNad Reduction (U.V.), Phosphohexose Isomerase
Device classClass I
Regulation21 CFR 862.1570
Review panelCH — Clinical Chemistry
Medical specialtyClinical Chemistry
Premarket route510(k) exempt

Compare with all 510(k) review times · Search every KLJ clearance

Top KLJ applicants

ApplicantClearancesLatest
Sigma Chemical Co.11977-06-17

Most recent KLJ clearances

510(k)ApplicantDeviceDecision dateReview days
K770577Sigma Chemical Co.DETER. OF PHOSPHOHEXOSE ISOMERASE1977-06-1781

Recalls for KLJ devices

openFDA lists no recalls for product code KLJ.

Frequently asked questions

What is FDA product code KLJ?

KLJ is the FDA product code for nad reduction (u.v.), phosphohexose isomerase. It is a Class I device, regulated under 21 CFR 862.1570 and reviewed by the Clinical Chemistry panel.

What device class is KLJ?

Class I, regulation 21 CFR 862.1570. Typical premarket route: 510(k) exempt.

How long does a 510(k) take for product code KLJ?

Across 1 cleared submissions the average was 81 days from receipt to decision (median 81).

Which companies have the most KLJ clearances?

Sigma Chemical Co. (1).

Next steps

Source: openFDA device classification, 510(k), PMA, De Novo and recall data (public domain). Review days run from FDA receipt to decision. Not regulatory advice.

All Clinical Chemistry product codes · FDA product code lookup · 510(k) database search · 510(k) review times